The marketing person always says 'it's around the corner'. I can make fun because I am a marketing guy. Lol. Their studies certainly are not as strong as AMBS. BD and ICON work makes theirs look weak. They are much farther off than the marketer lets on. That's how they get investors. AMBS is good to go with Lympro. They just need to move...